Bringing Car T Cell Therapy Trials to Underserved Populations

Authors

Hoda Badr
Rayne Rouce
Michael E Scheurer
Premal Lulla
Martha Mims
Pavan Reddy

Publication Date

12-11-2023

Journal

Cancer Cell

DOI

10.1016/j.ccell.2023.10.002

PMID

37890490

PMCID

PMC11146682

PubMedCentral® Posted Date

6-3-2024

PubMedCentral® Full Text Version

Author MSS

Published Open-Access

yes

Keywords

Humans, Vulnerable Populations, Immunotherapy, Adoptive, Medically Underserved Area, Minority Groups

Abstract

There is a critical need for equitable access to cell therapies in cancer treatment, particularly within public safety-net healthcare systems that serve minority and socioeconomically disadvantaged populations. We discuss how the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is piloting a cell therapy program aimed at addressing cancer care disparities and has the potential to serve as a national model for enhancing health equity in cancer care.